Jeffrey Leiden

Jeffrey Leiden

Chairman at VERTEX PHARMACEUTICALS INCORPORATED

Net worth: 8 M $ as of 2024-01-30

68 year
Health Technology
Commercial Services
Consumer Services

Profile

Jeffrey M. Leiden is a businessperson who founded CardioGene Therapeutics, Inc. and who has been at the head of 11 different companies. Dr. Leiden occupies the position of Executive Chairman of Vertex Pharmaceuticals, Inc., Non-Executive Chairman at Tmunity Therapeutics, Inc., Chairman at PathAI, Inc., Chairman for Casana Care, Inc. and Chairman of Revolution Healthcare Acquisition Corp. He is also Member of American Academy of Arts & Sciences, Member of Institute of Medicine, Member of Association of American Physicians, Member of American Society of Clinical Investigation and Member of National Academy of Medicine of United States and on the board of 6 other companies. In the past Dr. Leiden was Chairman at Lycera Corp., President & Chief Operating Officer of Abbott Laboratories, Chairman of TYRX, Inc., Chairman at Variation Biotechnologies (US), Inc., Managing Director at Clarus Ventures LLC, President & Chief Operating Officer at Pharmaceutical Products, Member of National Heart, Lung & Blood Institute, Chief Cardiology Officer at The University of Chicago, Professor at Harvard Medical School and Professor-Biological Sciences at Harvard T.H. Chan School of Public Health. He received a doctorate and an undergraduate degree from The University of Chicago.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
2024-02-14 18,336 ( 0.01% ) 8 M $ 2024-01-30

Jeffrey Leiden active positions

CompaniesPositionStart
VERTEX PHARMACEUTICALS INCORPORATED Chairman 2012-04-30
Director/Board Member -
Director/Board Member -
Director/Board Member -
Chairman -
Director/Board Member -
Corporate Officer/Principal -
American Society of Clinical Investigation Corporate Officer/Principal -
Director/Board Member -
░░░░░░ ░░░░░ ░░░░ ░░░░░░░░ -
░░░ ░░░░░░░░ ░░░░░░░░░░░ ░░ ░░░░ ░░░░░ ░░░░░░░░ ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ -
All active positions of Jeffrey Leiden

Former positions of Jeffrey Leiden

CompaniesPositionEnd
░░░░░░░░░░ ░░░░░░░░░░ ░░░░░░░░░░░ ░░░░░ ░░░░░░░ ░░░░░░░░░░
░░░░░░░ ░░░░░░░░░░░░░ ░░░░ ░░░░░░░░ ░░░░░░░░░░
░░░░░ ░░░░░░░░░░░ ░░░░░░░░░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
░░░░░░ ░░░░░ ░░░░░░░░ ░░░░░░░░░░
░░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
See the detail of Jeffrey Leiden's experience

Training of Jeffrey Leiden

The University of Chicago Doctorate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Jeffrey Leiden's experience

Connections

100 +

1st degree connections

42

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies4
ABBOTT LABORATORIES

Health Technology

VERTEX PHARMACEUTICALS INCORPORATED

Health Technology

QUEST DIAGNOSTICS INCORPORATED

Health Services

ASTRIA THERAPEUTICS, INC.

Health Technology

Private companies35

Finance

Health Technology

Commercial Services

Distribution Services

Health Technology

Electronic Technology

Commercial Services

Health Technology

Health Technology

Health Technology

Health Technology

Health Services

Commercial Services

Health Technology

Consumer Services

Finance

Commercial Services

Commercial Services

Consumer Services

Consumer Services

Health Technology

Pharmaceutical Products

American Society of Clinical Investigation

The American Association of Arts & Sciences

National Heart, Lung & Blood Institute

Government

Health Services

Commercial Services

Commercial Services

Commercial Services

Technology Services

Commercial Services

Health Services

Technology Services

Finance

Commercial Services

See company connections
  1. Stock
  2. Insiders
  3. Jeffrey Leiden
+229% on MICROSOFT CORPORATION since our purchase on January 11, 2019
Replicate our performance
fermer